Targeting PAX2 for the treatment of breast cancer

CAFC
  • US 8,080,534 B2
  • Filed: 02/18/2010
  • Issued: 12/20/2011
  • Est. Priority Date: 10/14/2005
  • Status: Active Grant
First Claim
Patent Images

1. A method for treating a breast condition in a subject, comprising administering to a breast tissue of the subject, a composition that (1) inhibits PAX2 expression or PAX2 activity, (2) expresses DEFB1 or (3) inhibits PAX2 expression or PAX2 activity and expresses DEFB1.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×